{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T05:34:38Z","timestamp":1735968878073,"version":"3.32.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1245\/s10434-024-16445-9","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T12:29:51Z","timestamp":1731673791000},"page":"629-631","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating Micro-RNA as a Predictive Biomarker for Radiation Response in Pancreas Cancer"],"prefix":"10.1245","volume":"32","author":[{"given":"Mark S.","family":"Etherington","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgos C.","family":"Karakousis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"issue":"3","key":"16445_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"16445_CR2","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1200\/EDBK_200861","volume":"38","author":"DB Evans","year":"2018","unstructured":"Evans DB. What makes a pancreatic cancer resectable? Am Soc Clin Oncol Educ Book. 2018;38:300\u20135. https:\/\/doi.org\/10.1200\/EDBK_200861. (PMID: 30231408).","journal-title":"Am Soc Clin Oncol Educ Book."},{"unstructured":"National Comprehensive Cancer Network. Pancreatic Adenocarcinoma (version 3.2024). Retrieved 10 September 2024 at http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/pancreatic.pdf","key":"16445_CR3"},{"key":"16445_CR4","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1200\/JCO.21.02233","volume":"40","author":"E Versteijne","year":"2022","unstructured":"Versteijne E, van Dam JL, Suker M, Janssen QP, Groothuis K, Akkermans-Vogelaar JM, Dutch Pancreatic Cancer Group, et al. Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the Dutch randomized PREOPANC trial. J Clin Oncol. 2022;40:1220\u201330. https:\/\/doi.org\/10.1200\/JCO.21.02233. (Epub 27 January2022. PMID: 35084987).","journal-title":"J Clin Oncol."},{"key":"16445_CR5","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1001\/jamaoncol.2022.2319.PMID:35834226;PMCID:PMC9284408","volume":"8","author":"MHG Katz","year":"2022","unstructured":"Katz MHG, Shi Q, Meyers J, Herman JM, Chuong M, Wolpin BM, et al. Efficacy of preoperative mFOLFIRINOX vs mFOLFIRINOX plus hypofractionated radiotherapy for borderline resectable adenocarcinoma of the pancreas: the A021501 phase 2 randomized clinical trial. JAMA Oncol. 2022;8:1263\u201370. https:\/\/doi.org\/10.1001\/jamaoncol.2022.2319.PMID:35834226;PMCID:PMC9284408.","journal-title":"JAMA Oncol."},{"issue":"5","key":"16445_CR6","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843\u201354. https:\/\/doi.org\/10.1016\/0092-8674(93)90529-Y. (PMID: 8252621).","journal-title":"Cell"},{"key":"16445_CR7","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nrg2634","volume":"10","author":"CM Croce","year":"2009","unstructured":"Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009;10:704\u201314. https:\/\/doi.org\/10.1038\/nrg2634. (PMID:19763153; PMCID:PMC3467096).","journal-title":"Nat Rev Genet."},{"key":"16445_CR8","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/s41388-024-03076-3","volume":"43","author":"GAD Metcalf","year":"2024","unstructured":"Metcalf GAD. MicroRNAs: circulating biomarkers for the early detection of imperceptible cancers via biosensor and machine-learning advances. Oncogene. 2024;43:2135\u201342. https:\/\/doi.org\/10.1038\/s41388-024-03076-3. (Epub 5 June 2024. PMID: 38839942; PMCID: PMC11226400).","journal-title":"Oncogene."},{"key":"16445_CR9","doi-asserted-by":"publisher","first-page":"8837","DOI":"10.1007\/s13277-014-2133-4","volume":"35","author":"Z Ding","year":"2014","unstructured":"Ding Z, Wu H, Zhang J, Huang G, Ji D. MicroRNAs as novel biomarkers for pancreatic cancer diagnosis: a meta-analysis based on 18 articles. Tumour Biol. 2014;35:8837\u201348. https:\/\/doi.org\/10.1007\/s13277-014-2133-4. (Epub 2 June 2014 PMID: 24880590).","journal-title":"Tumour Biol."},{"key":"16445_CR10","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.3390\/cancers15051358","volume":"15","author":"IP Yang","year":"2023","unstructured":"Yang IP, Yip KL, Chang YT, Chen YC, Huang CW, Tsai HL, et al. MicroRNAs as predictive biomarkers in patients with colorectal cancer receiving chemotherapy or chemoradiotherapy: a narrative literature review. Cancers Basel. 2023;15:1358. https:\/\/doi.org\/10.3390\/cancers15051358. (PMID: 36900159; PMCID: PMC10000071).","journal-title":"Cancers Basel."},{"key":"16445_CR11","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3390\/cancers14051171","volume":"14","author":"CCJ Lang","year":"2022","unstructured":"Lang CCJ, Lloyd M, Alyacoubi S, Rahman S, Pickering O, Underwood T, Breininger SP. The use of miRNAs in predicting response to neoadjuvant therapy in oesophageal cancer. Cancers Basel. 2022;14:1171. https:\/\/doi.org\/10.3390\/cancers14051171. (PMID: 35267476; PMCID: PMC8909542).","journal-title":"Cancers Basel."},{"key":"16445_CR12","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ejca.2009.10.027","volume":"46","author":"R Hummel","year":"2010","unstructured":"Hummel R, Hussey DJ, Haier J. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Eur J Cancer. 2010;46:298\u2013311. https:\/\/doi.org\/10.1016\/j.ejca.2009.10.027. (Epub 28 November 2009 PMID: 19948396).","journal-title":"Eur J Cancer."},{"key":"16445_CR13","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-024-16115-w","author":"H Ueda","year":"2024","unstructured":"Ueda H, Takahashi H, Kobayashi S, et al. miR-6855-5p enhances radioresistance and promotes migration of pancreatic cancer by inducing epithelial-mesenchymal transition via suppressing FOXA1: potential of plasma exosomal miR-6855-5p as an indicator of radiosensitivity in patients with pancreatic cancer. Ann Surg Oncol. 2024. https:\/\/doi.org\/10.1245\/s10434-024-16115-w.","journal-title":"Ann Surg Oncol."},{"key":"16445_CR14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41420-024-01936-1","volume":"10","author":"N Liu","year":"2024","unstructured":"Liu N, Wang A, Xue M, Zhu X, Liu Y, Chen M. FOXA1 and FOXA2: the regulatory mechanisms and therapeutic implications in cancer. Cell Death Discov. 2024;10:172. https:\/\/doi.org\/10.1038\/s41420-024-01936-1. (PMID: 38605023; PMCID: PMC11009302).","journal-title":"Cell Death Discov."},{"key":"16445_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.775238","volume":"12","author":"L Qiao","year":"2022","unstructured":"Qiao L, Chen Y, Liang N, Xie J, Deng G, Chen F, et al. Targeting epithelial-to-mesenchymal transition in radioresistance: crosslinked mechanisms and strategies. Front Oncol. 2022;12:775238. https:\/\/doi.org\/10.3389\/fonc.2022.775238. (PMID: 35251963; PMCID: PMC8888452).","journal-title":"Front Oncol."},{"key":"16445_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13014-023-02328-y","volume":"18","author":"IS Jan","year":"2023","unstructured":"Jan IS, Ch\u2019ang HJ. Selection of patients with pancreatic adenocarcinoma who may benefit from radiotherapy. Radiat Oncol. 2023;18:137. https:\/\/doi.org\/10.1186\/s13014-023-02328-y. (PMID: 37596627; PMCID: PMC10439654).","journal-title":"Radiat Oncol."},{"doi-asserted-by":"publisher","unstructured":"Zou R, Loke SY, Tang YC, Too HP, Zhou L, Lee ASG, Hartman M. Development and validation of a circulating microRNA panel for the early detection of breast cancer. Br J Cancer. 2022;126:472\u201381. https:\/\/doi.org\/10.1038\/s41416-021-01593-6. Epub 10 January2022. Erratum in Br J Cancer. 2024. https:\/\/doi.org\/10.1038\/s41416-024-02800-w. PMID: 35013577; PMCID: PMC8810862.","key":"16445_CR17","DOI":"10.1038\/s41416-021-01593-6 10.1038\/s41416-024-02800-w"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16445-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-16445-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16445-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T17:05:38Z","timestamp":1735923938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-16445-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["16445"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-16445-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"type":"print","value":"1068-9265"},{"type":"electronic","value":"1534-4681"}],"subject":[],"published":{"date-parts":[[2024,11,15]]},"assertion":[{"value":"17 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}